Работы, на которые ссылается эта работа

Работ: 215

Работа: Angiogenesis and prostate cancer: MicroRNAs comes into view

Без названия
ДругоеЦитирований: 3
ABI
Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton
Dos D. Sarbassov, Siraj M. Ali, Do‐Hyung Kim +5
Статья2004Цитирований: 2
ABI
Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer
Pedro C. Barata, Matthew M. Cooney, Prateek Mendiratta +3
Статья2018Цитирований: 2
ABI
Inhibition of transforming growth factor beta/<scp>SMAD</scp> signal by MiR‐155 is involved in arsenic trioxide‐induced anti‐angiogenesis in prostate cancer
Hui Ji, Yuan Li, Fei Jiang +4
Статья2014Цитирований: 2
ABI
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao, Bülent Arman Aksoy, Uğur Doğrusöz +10
Статья2013Цитирований: 2
ABI
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami, Jianjiong Gao, Uğur Doğrusöz +12
Статья2012Цитирований: 2
ABI
The Contribution of Angiogenesis to the Process of Metastasis
Diane R. Bielenberg, Bruce R. Zetter
Обзорная статья2015Цитирований: 2
ABI
Multiple angiogenesis stimulators in a single malignancy: Implications for anti-angiogenic tumour therapy
Helena Pavlaković, W. Havers, Lothar Schweigerer
Статья2001Цитирований: 2
ABI
MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence
Malathi Ramalinga, Arpita Roy, Anvesha Srivastava +5
Статья2015Цитирований: 2
ABI
Intricacies of Bevacizumab-Induced Toxicities and Their Management
Sarah M Gressett, Sachin Shah
Обзорная статья2009Цитирований: 2
ABI
Molecular Pathogenesis and Progression of Prostate Cancer
Randy S. Schrecengost, Karen E. Knudsen
Обзорная статья2013Цитирований: 2
ABI
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet, Rakesh K. Jain
Обзорная статья2011Цитирований: 2
ABI
MicroRNA-Based Therapeutics for Cancer
Vivien Wang, Wei Wu
Обзорная статья2009Цитирований: 2
ABI
PI3K/AKT signaling pathway and cancer: an updated review
Miriam Martini, Maria Chiara De Santis, Laura Braccini +2
Обзорная статья2014Цитирований: 2
ABI
The Role of PTEN in Tumor Angiogenesis
Stéphane Rodriguez, Uyen Huynh‐Do
Статья2011Цитирований: 2
ABI
Growing roles for the mTOR pathway
Dos D. Sarbassov, Siraj M. Ali, David M. Sabatini
Обзорная статья2005Цитирований: 2
ABI
MiR‐130b suppresses prostate cancer metastasis through down‐regulation of MMP2
Qin Chen, Xian Zhao, Hailong Zhang +8
Статья2014Цитирований: 2
ABI
Forty-Year Journey of Angiogenesis Translational Research
Yihai Cao, Jack L. Arbiser, Robert J. D’Amato +9
Обзорная статья2011Цитирований: 2
ABI
The Risk Factors of Prostate Cancer and Its Prevention: A Literature Review.
Noor Riza Perdana, Chaidir Arif Mochtar, H. Rainy Umbas +1
Статья2016Цитирований: 2
ABI
Hostile takeover: how tumours hijack pre‐existing vascular environments to thrive
Frank Winkler
Статья2017Цитирований: 2
ABI
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Nico van Zandwijk, Nick Pavlakis, Steven Kao +14
Статья2017Цитирований: 2
ABI
Reciprocal regulations between miRNAs and HIF-1α in human cancers
Wanli Yang, Jiaojiao Ma, Wei Zhou +6
Обзорная статья2018Цитирований: 2
ABI
Targeting Angiogenesis in Prostate Cancer
Zsombor Melegh, Sebastian Oltean
Обзорная статья2019Цитирований: 2
ABI
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer
Carlo Cattrini, Elena Castro, R. Lozano Mejorada +4
Обзорная статья2019Цитирований: 2
ABI
Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway
Santosh Kumar Singh, Tejumola Apata, Jennifer Gordetsky +1
Статья2019Цитирований: 2
ABI